Designer genes: Filling the gap in transplantation

Transplantation

Volumn 82, Issue 10, 2006, Pages 1261-1272

  Sarwal, Minnie M ^a,b   Li, Li ^a  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Genes; Genomics; Microarray; Rejection; Transplantation

Indexed keywords

CORTICOSTEROID; DACLIZUMAB; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TSUKUBAENOLIDE;

ACUTE GRAFT REJECTION; ARTIFICIAL NEURAL NETWORK; CHRONIC ALLOGRAFT NEPHROPATHY; DISEASE MARKER; DNA MICROARRAY; DNA SEQUENCE; FUNCTIONAL GENOMICS; GENE AMPLIFICATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ENGINEERING; GENOME; GENOMICS; HUMAN; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MICROARRAY ANALYSIS; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; TECHNOLOGY; UNSPECIFIED SIDE EFFECT;

GENETIC ENGINEERING; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; MULTIGENE FAMILY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRANSPLANTATION; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS;

EID: 33751537204     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000229436.89345.d0     Document Type: Review

References (61)

1. Morris ST, McMurray JJ, Rodger RS, et al. Endothelial dysfunction in renal transplant recipients maintained on cyclosporine. Kidney Int 2000; 57(3): 1100.
2. Zhang Y, Wroblewski M, Hertz MI, et al. Analysis of chronic lung transplant rejection by MALDI-TOF profiles of bronchoalveolar lavage fluid. Proteomics 2006; 6(3): 1001.
3. Traum AZ, Schachter AD. Transplantation proteomics. Pediatr Transplant 2005; 9(6): 700.
4. Nicholson JK, Connelly J, Lindon JC, Holmes E. Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov 2002; 1(2): 153.
5. Eickhoff B, Korn B, Schick M, et al. Normalization of array hybridization experiments in differential gene expression analysis. Nucleic Acids Res 1999; 27(22): e33.
6. Zien A, Aigner T, Zimmer R, Lengauer T. Centralization: a new method for the normalization of gene expression data. Bioinformatics 2001; 17 Suppl 1: S323.
7. Li C, Hung Wong W. Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application. Genome Biol 2001; 2(8): RESEARCH0032.
8. Ramdas L, Coombes KR, Baggerly K, et al. Sources of nonlinearity in cDNA microarray expression measurements. Genome Biol 2001; 2(11): RESEARCH0047.
9. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998; 95(25): 14863.
10. Tamayo P, Slonim D, Mesirov J, et al. Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. Proc Natl Acad Sci U S A 1999; 96(6): 2907.
11. Friedman N, Linial M, Nachman I, Pe'er D. Using Bayesian networks to analyze expression data. J Comput Biol 2000; 7(3-4): 601.
12. Yeung MK, Tegner J, Collins JJ. Reverse engineering gene networks using singular value decomposition and robust regression. Proc Natl Acad Sci U S A 2002; 99(9): 6163.
13. Basso K, Margolin AA, Stolovitzky G, Klein U, Dalla-Favera R, Califano A. Reverse engineering of regulatory networks in human B cells. Nat Genet 2005; 37(4): 382.
14. Avihingsanon Y, Ma N, Pavlakis M, et al. On the intraoperative molecular status of renal allografts after vascular reperfusion and clinical outcomes. J Am Soc Nephrol 2005; 16(6): 1542.
15. Tibshirani R, Hastie T, Narasimhan B, Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci U S A 2002; 99(10): 6567.
16. Khan J, Wei JS, Ringner M, et al. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat Med 2001; 7(6): 673.
17. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 2001; 98(9): 5116.
18. Golub TR, Slonim DK, Tamayo P, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999; 286(5439): 531.
19. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403(6769): 503.
20. Alter O, Brown PO, Botstein D. Singular value decomposition for genome-wide expression data processing and modeling. Proc Natl Acad Sci U S A 2000; 97(18): 10101.
21. Lee ML, Kuo FC, Whitmore GA, Sklar J. Importance of replication in microarray gene expression studies: statistical methods and evidence from repetitive cDNA hybridizations. Proc Natl Acad Sci U S A 2000; 97(18): 9834.
22. Bartosiewicz M, Trounstine M, Barker D, et al. Development of a toxicological gene array and quantitative assessment of this technology. Arch Biochem Biophys 2000; 376(1): 66.
23. Wu TD. Analysing gene expression data from DNA microarrays to identify candidate genes. J Pathol 2001; 195(1): 53.
24. Van Gelder RN, von Zastrow ME, Yool A, et al. Amplified RNA synthesized from limited quantities of heterogeneous cDNA. Proc Natl Acad Sci U S A 1990; 87(5): 1663.
25. Sarwal M, Chua MS, Kambham N, et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 2003; 349(2): 125.
26. Wang E, Miller LD, Ohnmacht GA, Liu ET, Marincola FM. High-fidelity mRNA amplification for gene profiling. Nat Biotechnol 2000; 18(4): 457.
27. Emmert-Buck MR, Bonner RF, Smith PD, et al. Laser capture microdissection. Science 1996; 274(5289): 998.
28. Sarwal MM, Jani A, Chang S, et al. Granulysin expression is a marker for acute rejection and steroid resistance in human renal transplantation. Hum Immunol 2001; 62(1): 21.
29. Liu CL, Prapong W, Natkunam Y, et al. Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays. Am J Pathol 2002; 161(5): 1557.
30. Ewton DZ, Lee K, Deng X, et al. Rapid turnover of cell-cycle regulators found in Mirk/dyrk1B transfectants. Int J Cancer 2003; 103(1): 21.
31. Goodstadt L, Ponting CP. Sequence variation and disease in the wake of the draft human genome. Hum Mol Genet 2001; 10(20): 2209.
32. Bammler T, Beyer RP, Bhattacharya S, et al. Standardizing global gene expression analysis between laboratories and across platforms. Nat Methods 2005; 2(5): 351.
33. Irizarry RA, Warren D, Spencer F, et al. Multiple-laboratory comparison of microarray platforms. Nat Methods 2005; 2(5): 345.
34. Butte AJ, Kohane IS. Creation and implications of a phenome-genome network. Nat Biotechnol 2006; 24(1): 55.
35. Halloran PF, Reeve J, Kaplan B. Lies, damn lies, and statistics: the perils of the P value. Am J Transplant 2006; 6(1): 10.
36. Michiels S, Koscielny S, Hill C. Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet 2005; 365(9458): 488.
37. Halloran PF. Immunosuppression in the post-adaptation period. Transplantation 2000; 70(1): 3.
38. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55(2): 713.
39. Hippen BE, DeMattos A, Cook WJ, et al. Association of CD20+ infiltrates with poorer clinical outcomes in acute cellular rejection of renal allografts. Am J Transplant 2005; 5(9): 2248.
40. Flechner SM, Kurian SM, Head SR, et al. Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes. Am J Transplant 2004; 4(9): 1475.
41. Aavik E, du Toit D, Myburgh E, et al. Estrogen receptor beta dominates in baboon carotid after endothelial denudation injury. Mol Cell Endocrinol 2001; 182(1): 91.
42. Du Toit D, Aavik E, Taskinen E, et al. Structure of carotid artery in baboon and rat and differences in their response to endothelial denudation angioplasty. Ann Med 2001; 33(1): 63.
43. Schuurs TA, Gerbens F, van der Hoeven JA, et al. Distinct transcriptional changes in donor kidneys upon brain death induction in rats: insights in the processes of brain death. Am J Transplant 2004; 4(12): 1972.
44. Sarwal M, Chang S, Barry C, et al. Genomic analysis of renal allograft dysfunction using cDNA microarrays. Transplant Proc 2001; 33(1-2): 297.
45. Scherer A, Krause A, Walker JR, et al. Early prognosis of the development of renal chronic allograft rejection by gene expression profiling of human protocol biopsies. Transplantation 2003; 75(8): 1323.
46. Hauser P, Schwarz C, Mitterbauer C, et al. Genome-wide gene-expression patterns of donor kidney biopsies distinguish primary allograft function. Lab Invest 2004; 84(3): 353.
47. Lopez-Navidad A, Caballero F. Extended criteria for organ acceptance. Strategies for achieving organ safety and for increasing organ pool. Clin Transplant 2003; 17(4): 308.
48. Terasaki PI, Cecka JM, Gjertson DW. Impact analysis: a method for evaluating the impact of factors in clinical renal transplantation. Clin Transpl 1998: 437.
49. Melk A, Mansfield ES, Hsieh SC, et al. Transcriptional analysis of the molecular basis of human kidney aging using cDNA microarray profiling. Kidney Int 2005; 68(6): 2667.
50. Li B, Hartono C, Ding R, et al. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med 2001; 344(13): 947.
51. Vasconcellos LM, Schachter AD, Zheng XX, et al. Cytotoxic lymphocyte gene expression in peripheral blood leukocytes correlates with rejecting renal allografts. Transplantation 1998; 66(5): 562.
52. Strehlau J, Pavlakis M, Lipman M, et al. Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. Proc Natl Acad Sci U S A 1997; 94(2): 695.
53. Horwitz PA, Tsai EJ, Putt ME, et al. Detection of cardiac allograft rejection and response to immunosuppressive therapy with peripheral blood gene expression. Circulation 2004; 110(25): 3815.
54. Satterwhite T, Chua MS, Hsieh SC, et al. Increased expression of cytotoxic effector molecules: different interpretations for steroid-based and steroid-free immunosuppression. Pediatr Transplant 2003; 7(1): 53.
55. Muthukumar T, Dadhania D, Ding R, et al. Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med 2005; 353(22): 2342.
56. Ding R, Li B, Muthukumar T, et al. CD103 mRNA levels in urinary cells predict acute rejection of renal allografts. Transplantation 2003; 75(8): 1307.
57. Chua MS, Barry C, Chen X, et al. Molecular profiling of anemia in acute renal allograft rejection using DNA microarrays. Am J Transplant 2003; 3(1): 17.
58. Deng MC, Eisen HJ, Mehra MR, et al. Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant 2006; 6(1): 150.
59. Sarwal MM, Yorgin PD, Alexander S, et al. Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation. Transplantation 2001; 72(1): 13.
60. Zhang HQ, Lu H, Enosawa S, et al. Microarray analysis of gene expression in peripheral blood mononuclear cells derived from long-surviving renal recipients. Transplant Proc 2002; 34(5): 1757.
61. Mansfield ES, Sarwal MM. Arraying the orchestration of allograft pathology. Am J Transplant 2004; 4(6): 853.